PHACTR4
Basic information
Region (hg38): 1:28369582-28500364
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (87 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PHACTR4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001048183.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 81 | 86 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 81 | 5 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| PHACTR4 | protein_coding | protein_coding | ENST00000373836 | 13 | 130768 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.00000284 | 0.999 | 124775 | 1 | 34 | 124810 | 0.000140 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.10 | 334 | 396 | 0.844 | 0.0000212 | 4635 |
| Missense in Polyphen | 103 | 137.67 | 0.74814 | 1599 | ||
| Synonymous | 0.987 | 126 | 141 | 0.894 | 0.00000750 | 1429 |
| Loss of Function | 2.97 | 15 | 33.5 | 0.447 | 0.00000202 | 387 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000285 | 0.000285 |
| Ashkenazi Jewish | 0.000298 | 0.000298 |
| East Asian | 0.000111 | 0.000111 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000168 | 0.000168 |
| Middle Eastern | 0.000111 | 0.000111 |
| South Asian | 0.000164 | 0.000131 |
| Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Regulator of protein phosphatase 1 (PP1) required for neural tube and optic fissure closure, and enteric neural crest cell (ENCCs) migration during development. Acts as an activator of PP1 by interacting with PPP1CA and preventing phosphorylation of PPP1CA at 'Thr-320'. During neural tube closure, localizes to the ventral neural tube and activates PP1, leading to down-regulate cell proliferation within cranial neural tissue and the neural retina. Also acts as a regulator of migration of enteric neural crest cells (ENCCs) by activating PP1, leading to dephosphorylation and subsequent activation of cofilin (COF1 or COF2) and repression of the integrin signaling through the RHO/ROCK pathway (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.0662
Intolerance Scores
- loftool
- 0.862
- rvis_EVS
- -0.44
- rvis_percentile_EVS
- 24.53
Haploinsufficiency Scores
- pHI
- 0.0406
- hipred
- N
- hipred_score
- 0.379
- ghis
- 0.492
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.202
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Phactr4
- Phenotype
- cellular phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; embryo phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- neural crest cell migration;neural tube closure;Rho protein signal transduction;actin cytoskeleton organization;positive regulation of catalytic activity;regulation of phosphoprotein phosphatase activity;enteric nervous system development;regulation of cell cycle;closure of optic fissure;negative regulation of integrin-mediated signaling pathway
- Cellular component
- cytoplasm;lamellipodium
- Molecular function
- actin binding;protein phosphatase 1 binding;protein phosphatase activator activity